• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

体外检测评估 CAR-T 细胞细胞毒性。

In vitro assays to evaluate CAR-T cell cytotoxicity.

机构信息

Department of Pharmacology, Physiology, & Cancer Biology, Thomas Jefferson University, Philadelphia, PA, United States.

Department of Pharmacology, Physiology, & Cancer Biology, Thomas Jefferson University, Philadelphia, PA, United States; Department of Microbiology & Immunology, Thomas Jefferson University, Philadelphia, PA, United States; Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA, United States.

出版信息

Methods Cell Biol. 2024;183:303-315. doi: 10.1016/bs.mcb.2023.05.009. Epub 2023 Oct 24.

DOI:10.1016/bs.mcb.2023.05.009
PMID:38548415
Abstract

This chapter introduces four commonly used in vitro chimeric antigen receptor (CAR)-T cell cytotoxicity assays (lactate dehydrogenase release assay, Cr release assay, IncuCyte live cell killing assay, and xCELLigence real-time analysis) and provides a detailed protocol for xCELLigence real-time analysis. Focusing on in vitro assays, this chapter starts with explaining the mechanisms and discussing the utilization of each assay to quantify T-cell-induced cytotoxicity. Due to the high-throughput quantification and straightforward workflow of xCELLigence real-time analysis, a protocol entailing reagents and equipment, a 3-day step-by-step procedure, and instructions for data analysis are provided.

摘要

本章介绍了四种常用的体外嵌合抗原受体(CAR)-T 细胞细胞毒性测定法(乳酸脱氢酶释放测定法、Cr 释放测定法、IncuCyte 活细胞杀伤测定法和 xCELLigence 实时分析),并提供了 xCELLigence 实时分析的详细方案。本章侧重于体外测定法,首先解释了每种测定法的机制和用途,以量化 T 细胞诱导的细胞毒性。由于 xCELLigence 实时分析具有高通量定量和简单的工作流程,因此提供了包含试剂和设备、为期 3 天的分步程序以及数据分析说明的方案。

相似文献

1
In vitro assays to evaluate CAR-T cell cytotoxicity.体外检测评估 CAR-T 细胞细胞毒性。
Methods Cell Biol. 2024;183:303-315. doi: 10.1016/bs.mcb.2023.05.009. Epub 2023 Oct 24.
2
Evaluation of CAR-T cell cytotoxicity: Real-time impedance-based analysis.CAR-T 细胞细胞毒性的评估:基于实时阻抗的分析。
Methods Cell Biol. 2022;167:81-98. doi: 10.1016/bs.mcb.2021.08.002. Epub 2021 Sep 27.
3
An impedance-based cytotoxicity assay for real-time and label-free assessment of T-cell-mediated killing of adherent cells.基于阻抗的细胞毒性检测法,用于实时、无标记评估 T 细胞介导的贴壁细胞杀伤作用。
J Immunol Methods. 2014 Mar;405:192-8. doi: 10.1016/j.jim.2014.01.012. Epub 2014 Jan 29.
4
A Real-time Potency Assay for Chimeric Antigen Receptor T Cells Targeting Solid and Hematological Cancer Cells.一种针对实体瘤和血液癌细胞的嵌合抗原受体T细胞的实时效价测定法。
J Vis Exp. 2019 Nov 12(153). doi: 10.3791/59033.
5
Epigenetic Priming of Bladder Cancer Cells With Decitabine Increases Cytotoxicity of Human EGFR and CD44v6 CAR Engineered T-Cells.地西他滨对膀胱癌细胞的表观遗传引发作用增强了人 EGFR 和 CD44v6 CAR 工程化 T 细胞的细胞毒性。
Front Immunol. 2021 Nov 17;12:782448. doi: 10.3389/fimmu.2021.782448. eCollection 2021.
6
High-Throughput Image Cytometry Detection Method for CAR-T Transduction, Cell Proliferation, and Cytotoxicity Assays.高通量图像细胞术检测 CAR-T 转导、细胞增殖和细胞毒性分析方法。
Cytometry A. 2021 Jul;99(7):689-697. doi: 10.1002/cyto.a.24267. Epub 2020 Nov 28.
7
High-Throughput Flow Cytometric Method for the Simultaneous Measurement of CAR-T Cell Characterization and Cytotoxicity against Solid Tumor Cell Lines.高通量流式细胞术同时测量 CAR-T 细胞特征和对实体瘤细胞系的细胞毒性的方法。
SLAS Discov. 2018 Aug;23(7):603-612. doi: 10.1177/2472555218768745. Epub 2018 Apr 10.
8
A versatile flow-based assay for immunocyte-mediated cytotoxicity.一种多功能的基于流动的免疫细胞介导的细胞毒性测定法。
J Immunol Methods. 2019 Nov;474:112668. doi: 10.1016/j.jim.2019.112668. Epub 2019 Sep 13.
9
Potency monitoring of CAR T cells.嵌合抗原受体T细胞(CAR T细胞)的效力监测
Methods Cell Biol. 2023;173:173-189. doi: 10.1016/bs.mcb.2022.07.010. Epub 2022 Sep 6.
10
Enhanced cytotoxicity against solid tumors by bispecific antibody-armed CD19 CAR T cells: a proof-of-concept study.双特异性抗体武装的 CD19 CAR T 细胞增强对实体瘤的细胞毒性:概念验证研究。
J Cancer Res Clin Oncol. 2020 Aug;146(8):2007-2016. doi: 10.1007/s00432-020-03260-4. Epub 2020 May 24.

引用本文的文献

1
Engineering safe anti-CD19-CD28ζ CAR T cells with CD8a hinge domain in serum-free media for adoptive immunotherapy.在无血清培养基中构建具有CD8a铰链区的安全抗CD19-CD28ζ嵌合抗原受体T细胞用于过继性免疫治疗
Front Immunol. 2025 May 9;16:1545549. doi: 10.3389/fimmu.2025.1545549. eCollection 2025.